Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2000
05/17/2000CN1253502A Method of using cyclooxygenase-2 inhibitors in prevention of cardiovascular disorders
05/17/2000CN1253501A IL-8 receptor antagonists
05/17/2000CN1253500A Polythiophene anti-tumor agents
05/17/2000CN1253499A Drug composition
05/17/2000CN1253498A Process for enhancing immune response in animals using 'beta'-carotene as dietary supplement
05/17/2000CN1253497A Swallow tablet comprising paracetamol
05/17/2000CN1253493A Skin care compositions containing combinations of compounds for mimicking effect on skin of retinoic acid
05/17/2000CN1253486A Method for removing superfluous hairs
05/17/2000CN1253474A Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
05/17/2000CN1253138A Structure and usage of antisense oligonucleotide for treating diseases correlative to hepatitis C virus
05/17/2000CN1253136A Thiazolidine derivatives and medicinal application thereof
05/17/2000CN1253135A Benzisoelenazolone sulfamide derivative, its preparing process and its application in preparing medicines
05/17/2000CN1253032A Microcapsule containing core material and its producing method
05/17/2000CN1253022A Composition used to enhance permeability of skin medicament
05/17/2000CN1253019A Method for preparing medicine composition capable of inhibiting post infective virus proteinase
05/17/2000CN1253000A Exterior-applied medicine 'Yiganzhuanyin liquid' for transforming surface antigen of hepatitis B from positive to negative
05/17/2000CN1252993A Gargarism for treating oral diseases
05/17/2000CN1252992A Carboprost methylate preparation able to be absorbed via oral mucosa and its preparing process
05/17/2000CN1252990A Vitamin A stable cleaning composition
05/17/2000CN1052489C Process for preparation of 16 alpha-methyl steroids
05/17/2000CN1052482C Camptothecin derivatives, preparations thereof and antitumor agents
05/17/2000CN1052481C Platelet activating factor antagonist and preparation thereof
05/17/2000CN1052420C Chinese medicine for curing burn and traumatic wound and its production method
05/17/2000CN1052402C Oligosaccharid type antipsychotic
05/17/2000CN1052401C Medicaments
05/17/2000CN1052400C 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzole as anti-depression medicine
05/17/2000CN1052399C Smell covered-up medicine composition
05/17/2000CN1052398C Pharmaceutical spheroid formulation
05/17/2000CN1052397C Method for preparing pharmaceutical beadlets
05/17/2000CN1052386C Functional food for lowering blood-sugar, blood-lipid and blood-pressure
05/16/2000USRE36701 Coronary heart disease treated with oestradiol
05/16/2000US6064720 Magnetic support for removable antiscatter grid
05/16/2000US6063964 5-hydroxymethyl-2-aminotetralins as cardiovascular agents
05/16/2000US6063962 Process for the preparation of NMDA antagonists
05/16/2000US6063935 Cultivating a bacteria of a bacillus genus capable of producing 3,3-dihydroxyazetidine or salt thereof to produce the 3,3-dihydroxyazetidine or salt in culture medium and collecting the product
05/16/2000US6063934 Neuropeptide y antagonists
05/16/2000US6063927 Paroxetine derivatives
05/16/2000US6063923 Cyclization of 4-ethyl-4-hydroxy-7-(7-iodo-9-(4-methyl piperazin-1-ylmethyl)-2,3-dihydro-(1,4)dioxino(2,3-g)quinolin -8-ylmethyl)-4,7-dihydro-1h-pyrano(3,4-c)pyridine-3,8-dione, resolving mixture to yield desired enantiomer
05/16/2000US6063918 Reacting a base with a 2-azetidinyl-3,4-dihalogeno-2-butenoic acid compound in an aqueous organic solvent to yield a cyclized isooxacephalosporin derivative; simplification
05/16/2000US6063911 Methods and compositions for treatment of cell proliferative disorders
05/16/2000US6063821 Antiinflammatory agents and extrusion for administering and antipyretics
05/16/2000US6063819 Neuroprotective poly-guanidino compounds which block presynaptic N and P/Q calcium channels
05/16/2000US6063818 Ethers or alkoxy and amide derivatives
05/16/2000US6063817 Antiischemic agents
05/16/2000US6063816 Hydroxamic acid compounds
05/16/2000US6063815 Treatment of metabolic disorders
05/16/2000US6063814 Antileukemia agents and anticarcinogenic agents
05/16/2000US6063812 Angiogenesis inhibitors, antiarthritic agents and anticarcinogenic agents plus synthesis
05/16/2000US6063811 Compositions for a once day treatment of cyclooxygenase-2 mediated diseases
05/16/2000US6063810 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof
05/16/2000US6063809 Anti-first-pass effect compounds
05/16/2000US6063808 Methods and compositions for treating urinary incontinence using enantiomerically enriched (S,S)-glycopyrrolate
05/16/2000US6063807 Cyclo-oxygenase inhibitor and amidine derivatives salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts
05/16/2000US6063805 Hypotensive agents with n-acetylserotonin
05/16/2000US6063804 Pyrrole compounds
05/16/2000US6063802 Ondansetron freeze-dried dosage form compositions for oral administration
05/16/2000US6063801 Heterocyclic topoisomerase poisons
05/16/2000US6063799 Antiinflammatory agents, gastrointestinal disorders and antiarthritic agents
05/16/2000US6063797 γ-RAR antagonist ligand or α-RAR agonist ligand as an apoptosis inhibitor
05/16/2000US6063796 Heterocyclic compounds of piperidine
05/16/2000US6063795 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
05/16/2000US6063792 Methods and compositions for treating urinary incontinence using enantiomerically enriched (S)-trihexyphenidyl
05/16/2000US6063791 N-benzenesulfonyl-L-proline derivatives, method for preparing and therapeutic use
05/16/2000US6063789 Antiinflammatory agents
05/16/2000US6063788 Treatmrnt of artheriosclerosis
05/16/2000US6063787 Methods for the treatment of psoriasis and genital warts
05/16/2000US6063784 Heteroaryloxyethylamines, method of preparation, application as medicine and pharmaceutical compositions containing them
05/16/2000US6063783 Analgesics and administering for treatment of pain
05/16/2000US6063782 Pyrrolopyridazine derivatives
05/16/2000US6063780 Method of treating a tumor
05/16/2000US6063778 Cephalosporin derivatives and processes for the preparation thereof
05/16/2000US6063776 Anticholesterol agents
05/16/2000US6063775 Viricides for treatment of aids
05/16/2000US6063774 Tricyclic quinoxaline derivatives as neuroprotective agents
05/16/2000US6063773 Cellulose sulfate for use as antimicrobial and contraceptive agent
05/16/2000US6063772 Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes
05/16/2000US6063771 Formulations for controlling human lice
05/16/2000US6063770 Tannic acid compositions for treating cancer
05/16/2000US6063769 1-thiogalactose derivatives
05/16/2000US6063628 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA
05/16/2000US6063613 Auxiliary genes and proteins of methicillin resistant bacteria and antagonists thereof
05/16/2000US6063593 TGFβ1 responsive bone marrow derived cells to express a recombinant protein
05/16/2000US6063585 Tumor necrosis factor receptor associated factor regulated protein product; for the prevention of tumors cause by epstein barr virus; antitumor agents
05/16/2000US6063569 Methods for automated synthesis of PNA-DNA chimeras and compositions thereof
05/16/2000US6063566 Enzymatic ribonucleic acid molecule which catalyzes the position preferential cleavage of single-stranded deoxyribonucleic
05/16/2000US6063407 Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
05/16/2000US6063405 Sustained release delivery system
05/16/2000US6063403 Compressed dry-granulation desogestrel tablets
05/16/2000US6063400 Targeted liposomal constructs for diagnostic and therapeutic uses
05/16/2000US6063395 Sustained rlease
05/16/2000US6063394 Injection formulations of avermectins and milbemycins based on castor oil
05/16/2000US6063381 Therapy for deep tissue or fungicide
05/16/2000US6063373 Enhanced activation of NK cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor
05/16/2000US6063363 Treatment for upper respiratory tract infections with potassium salts
05/16/2000US6063116 Modulation of cell proliferation and wound healing
05/16/2000CA2215020C Tetrazolyl-substituted quinuclidines as substance p antagonists
05/16/2000CA2191920C Derivatives of 3-deoxy 16-membered ring macrolide antibiotics
05/16/2000CA2180263C Diazabicyclic neurokinin antagonists
05/16/2000CA2173403C External therapeutic composition for dermatitis
05/16/2000CA2170255C Pharmaceutical composition for immunoenhancement therapy
1 ... 6318 6319 6320 6321 6322 6323 6324 6325 6326 6327 6328 6329 6330 6331 6332 6333 6334 6335 6336 6337 6338 ... 7860